Risk Factor Analysis of Restless Legs Syndrome in Type 2 Diabetes Mellitus Patients

R. Regi Bai, Ramesh Kumari

Abstract


Background: Diabetes is a global epidemic in India. The highest prevalence is estimated of 79.4 million by 2030. Diabetes Mellitus has been associated with secondary form of RLS. Aim: This study is to assess the possible risk factor for RLS development in Type 2 Diabetes Mellitus patients. Methods: This retrospective study focused on 120 Type 2 Diabetes Mellitus patients who were selected by using convenient sampling technique. The tool consisted of three parts: Part I was socio-demographic variables; Part II was clinical and Part III consisted of RLS rating scale. Result: The majority of the patients were with more than 10 years duration of Diabetes Mellitus, and 42.5% of the patients are obese. In relation to glycemic control, 67.5% of the patients were with HbA1c of more than 7. The majority of the patients (60.8%) were with raised fasting blood glucose and 74.2% of the patients with raised postprandial blood sugar level. There was significant association of severity of RLS with demographic variables like age, education, marital status, income, duration of diabetes, HbA1c, postprandial blood sugar, use of physical exercise, episode of hypoglycemia during last month and comorbidity at 0.05 levels. Conclusion: This study suggests that glycemic control has an association between RLS and type 2 diabetes mellitus subjects. Proper, early diagnosis and treatment of RLS may go a long way in reducing morbidity and probably mortality in diabetic patients.


Full Text:

PDF

References


American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2004; 27(Suppl 1): S15–35p.

World Health Organization. Global Report on Diabetes. ‎2016). [Online] Available from https://www.who.int/

diabetes/global-report/en/.

Trenkwalder C, Allen R, Högl B, et al. Comorbidities, Treatment, and Pathophysiology in RLS. Lancet Neurol. 2018; 17(1): 994–1005p.

Karl Ekbom, Ulfberg J. Restless Legs Syndrome. J Intern Med. 2009; 266(5): 419–31p.

Trenkwalder C, Paulus W. RLS: Pathophysiology, Clinical Presentation and Management. Nature Reviews Neurology. 2010; 6(6): 337–346p.

Benes H, Walters AS, Allen RP, et al. Definition of RLS, How to Diagnose It, and How to Differentiate It from RLS Mimics. Mov Disord. 2007; 22(Suppl 18): 401–408p.

Phillips B, Young T, Finn L, et al. Epidemiology of RLS in Adults. Arch Intern Med. 2000; 160(1): 2137–41p.

Merlino G, Fratticci L, Valente M, et al. Association of Restless Legs Syndrome in Type 2 Diabetes: A Case-Control Study. Sleep. 2007; 30(7): 866–871p.

Mehdi Zobeiri, Azita Shokoohi. Restless Leg Syndrome in Diabetics Compared with Normal Controls. Sleep Disord. 2014; 871751p.

Allen RP, Walters AS, Montplaisir J, et al. RLS Prevalence and Impact. REST General Population Study. Arch Intern Med. 2005; 165(1): 1286–1292p.

Ohayon MM, Roth T. Prevalence of RLS and Periodic Limb Movement Disorder in the General Population. J Psychosom Res. 2002; 53(1): 547–54p.

Mitchell UH. Nondrug-Related Aspect of Treating Ekbom Disease, formerly known as RLS. Neuropsychiatric Disorder Treat. 2011; 7(1): 251–7p.

Seydahmet Akın, Cem Bölük, Ülkü Türk Börü, et al. Restless Leg Syndrome as Comorbidity in Type 2 Diabetes Mellitus. Prim Care Diabetes. 2019; 13(1): 87–91p.

Salma Batool-Anwar, Yanping Li, Katerina De Vito, et al. Lifestyle Factors and Risk of RLS: Prospective Cohort Study. J Clin Sleep Med. 2016; 12(2): 187–194p.

Mihyun Jeong. Associations of Depression, Sleep, and Acculturation on Glycemic Control in Korean Americans with Type 2 Diabetes Mellitus. 2017. [Online] Available from https://repository.asu.edu/items/

#embed


Refbacks

  • There are currently no refbacks.